Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
5.19
-0.02 (-0.38%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Valneva SE Employees
Valneva SE had 674 employees as of December 31, 2025. The number of employees decreased by 39 or -5.47% compared to the previous year.
Employees
674
Change (1Y)
-39
Growth (1Y)
-5.47%
Revenue / Employee
$267,434
Profits / Employee
-$236,131
Market Cap
482.77M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cabaletta Bio | 158 |
| Sutro Biopharma | 133 |
| Neurogene | 131 |
| Kyverna Therapeutics | 129 |
| Ocugen | 116 |
| Artiva Biotherapeutics | 106 |
| C4 Therapeutics | 104 |
| Silence Therapeutics | 88 |
VALN News
- 1 day ago - Valneva SE Extraordinary Shareholders Meeting Transcript - GuruFocus
- 1 day ago - Valneva Announces Successful Outcome of its Annual General Meeting - GlobeNewsWire
- 22 days ago - Valneva files to sell 31.79M ordinary shares for holders - TheFly
- 22 days ago - Valneva SE Registration statement: Registration filing - Filings
- 23 days ago - Valneva Announces Availability of Documentation for its Annual General Meeting - GlobeNewsWire
- 23 days ago - Valneva SE Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 24 days ago - Valneva SE Slides: Investor presentation - Filings
- 4 weeks ago - Valneva to Participate at U.S. and European Investor Conferences in June - GlobeNewsWire